ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
DBV CMO leaves as peanut allergy player rejigs team in wake of BLA withdrawal
January 07, 2019Lucia Septién-Velez has stepped down (PDF) as chief medical officer of DBV Technologies. The departure of Septién-Velez is part of a wider reshuffle that gives DBV’s management a new look as it seeks to get its BLA back on track..... -
DBV pulls peanut allergy filing after FDA faults data details
December 25, 2018DBV Technologies has withdrawn the filing for FDA approval of its peanut allergy therapy. The French biotech pulled the BLA after talks with the agency revealed gaps in the manufacturing and quality-control sections of the filing....
Pharma Sources Insight January 2025
